De Novo Submission Made for Flu Molecular Test
Cue Health has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue Flu Molecular Test.
Read More
Search Results for: covid-19
SARS-CoV-2 Saliva Test Now Available
MicroGEM and AiTmed have announced the MicroGEM Sal6830 SARS-CoV-2 Saliva Test is now available to AiTmed’s network of healthcare providers.
Read More
How oncRNA Technology Could Revolutionize Cancer Diagnostics
Exai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read More
Understanding the Point of Care Revolution
Of all the changes caused by the COVID-19 pandemic, the evolution of POC and home testing is perhaps the biggest. CLP Director of Business Intelligence Chris Wolski and Hamid Erfanian, CEO of Enzo Biochem, an integrated healthcare company focused on offering life sciences, including reagents, clinical testing and molecular diagnostic products, do a deep dive on the history of POC testing, how and why it became ubiquitous during COVID-19, and what this ubiquity means for the future of the clinical laboratory.
Read More
Cedars-Sinai Team Pioneers Liver Cancer Blood Test
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read More